Prostate SABR With Intra-Prostatic SABR Boost: A Phase II Study
Who is this study for? Adult patients with prostate cancer
What treatments are being studied? Pelvic SABR with intra-prostatic SABR
Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
Stereotactic Ablative Radiation (SABR/SBRT) will be prescribed to a dose of 35 Gy in 5 fractions, once weekly to prostate with a simultaneous intra-prostatic boost to the MR detected nodule up to 50Gy. The pelvic lymph nodes and seminal vesicles will also receive 25 Gy in 5 weekly fractions.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Histologically confirmed prostate adenocarcinoma
• High-risk prostate cancer, defined as at least one of: T3, Gleason 8-10, OR PSA \> 20 ng/mL
• Willing to give informed consent to participate in this clinical trial
Locations
Other Locations
Saudi Arabia
King Saud University Medical City
RECRUITING
Riyadh
Contact Information
Primary
Yasir Alayed, MD
yalayed@ksu.edu.sa
+966114671546
Time Frame
Start Date: 2019-12-26
Estimated Completion Date: 2026-12
Participants
Target number of participants: 30
Treatments
Experimental: Experimental arm
SABR 35Gy/5 to prostate, up to 50Gy/5 to MR nodule, and 25Gy/5 to pelvic nodes and SVs
Related Therapeutic Areas
Sponsors
Leads: King Saud University